Seattle, WA, United States of America

Mark A Moehring

This inventor holds 39 USPTO granted patents and 10 published patent applications and 6 EPO patents, primarily in Ultrasound Technology. Top assignees: Otonexus Medical Technologies, Inc., Spentech, Inc., Applied Physiology and Medicine. Active years: 1991-2026.

USPTO Granted Patents = 39 

% Patents Active = 89.7

 

Average Co-Inventor Count = 2.7

ph-index = 13

Forward Citations = 942(Granted Patents)


Company Filing History:


Years Active: 1991-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Ultrasound Technology
Doppler Ultrasound
Tympanic Membrane
Otitis Media
Capacitive Transducers
Medical Imaging
Machine Learning
Auscultation Device
Optical Coherence Tomography
Non-Invasive Monitoring
Blood Flow Detection
Compartment Syndrome
39 patents (USPTO):Explore Patents

Title: Mark A Moehring: Innovating Medical Ultrasonics

Introduction

Mark A Moehring, a prominent inventor based in Seattle, WA, holds an impressive portfolio of 33 patents. His innovative work primarily focuses on advancements in ultrasound technology, contributing significantly to the field of medical diagnostics and treatment.

Latest Patents

Among his latest patents are groundbreaking inventions that enhance the characterization of various membrane properties through ultrasound signal processing. One notable patent describes an apparatus and method for characterizing a ductile membrane. This innovation utilizes an excitation generator to cause displacement of a membrane or surface while a series of ultrasound pulses are applied. By analyzing phase differences between transmitted and received signals, practitioners can determine the movement of the membrane or surface in response to excitation. This examination aids in identifying the fluid type behind the membrane, including no fluid, serum fluid, or purulent fluid.

Another significant patent focuses on the characterization of acute otitis media. In this case, an ultrasound signal processor also employs an excitation generator to displace the tympanic membrane while ultrasound pulses are applied. The analysis of phase response in this scenario provides critical insights into the fluid type behind the tympanic membrane, thereby contributing to accurate diagnoses and treatment options for patients suffering from this condition.

Career Highlights

Throughout his career, Mark Moehring has made substantial contributions to the field by working with innovative companies. His experience includes tenure at Otonexus Medical Technologies, Inc. and Spentech, Inc., where he has worked on developing cutting-edge applications of ultrasound technology.

Collaborations

Mark has collaborated with notable colleagues, including George A Gates and Jay A Chesavage, to advance medical technologies that improve diagnostic capabilities. These partnerships underscore the collaborative nature of innovation and the shared goals of improving healthcare through technology.

Conclusion

Mark A Moehring stands out as a significant figure in the realm of medical ultrasonics, with a track record that exemplifies the power of innovation in improving diagnostic methodologies. His numerous patents reflect a commitment to enhancing patient care, and his collaborations further demonstrate the importance of teamwork in the pursuit of technological advancements.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…